• Clinical Evidence

Safety and Effectiveness of the Use of an Electronic Glucose Monitoring System Versus Weight-Based Dosing Nomogram for Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome in a VA Hospital

Setting: 159-bed Level 1A tertiary care VA hospital

Objective

This retrospective study compares the safety and effectiveness of an electronic glucose monitoring system (EndoTool) versus paper-based protocols for patients with diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar syndrome (HHS) treated with intraveous insulin in the emergency department or an intensive care unit.

Setting

159-bed Level 1A tertiary care VA hospital.

Results

  • Incidence of hypoglycemia <70 mg/dL decreased 60.3% with EndoTool, from 0.0604% to 0.024% of patients.
  • Incidence of hyperglycemia >=200 mg/dL decreased 17.4%, from 55.7% to 46.0% of blood glucose readings.
  • Percentage of blood glucose readings within the target range of 140-180 mg/dL increased 60.1% with EndoTool; from 16.3% to 26.1%.
  • Percentage of on-time blood glucose checks increased 53.4% with EndoTool, from 52.6% to 80.7%, indicating improved nursing compliance.

Conclusions

Use of an electronic glucose monitoring system (EndoTool) for managing diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) has potential for increasing the safety and effectiveness of glycemic control and minimizing glycemic variability; it is shown to deliver significantly lower incidence of hypoglycemia and hyperglycemia than paper-based protocols as well as a greater percentage of blood glucose readings in range and improved nursing compliance with blood glucose checks.

Objective

This retrospective study compares the safety and effectiveness of an electronic glucose monitoring system (EndoTool) versus paper-based protocols for patients with diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar syndrome (HHS) treated with intraveous insulin in the emergency department or an intensive care unit.

Setting

159-bed Level 1A tertiary care VA hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 60.3% with EndoTool, from 0.0604% to 0.024% of patients.
  • Incidence of hyperglycemia >=200 mg/dL decreased 17.4%, from 55.7% to 46.0% of blood glucose readings.
  • Percentage of blood glucose readings within the target range of 140-180 mg/dL increased 60.1% with EndoTool; from 16.3% to 26.1%.
  • Percentage of on-time blood glucose checks increased 53.4% with EndoTool, from 52.6% to 80.7%, indicating improved nursing compliance.
Conclusions

Use of an electronic glucose monitoring system (EndoTool) for managing diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) has potential for increasing the safety and effectiveness of glycemic control and minimizing glycemic variability; it is shown to deliver significantly lower incidence of hypoglycemia and hyperglycemia than paper-based protocols as well as a greater percentage of blood glucose readings in range and improved nursing compliance with blood glucose checks.

References

Authors

Madeline Brown, PharmD; Justin Roberts, PharmD, BCPS; Cole Smith, PharmD, BCPS; Dakota Eash, PharmD Candidate.

Source

Published in Journal of Diabetes Science and Technology.

Year

2023 (Print) 2022 (Online)

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study compares the safety and effectiveness of an electronic glucose monitoring system (EndoTool) versus paper-based protocols for patients with diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar syndrome (HHS) treated with intraveous insulin in the emergency department or an intensive care unit.

Setting

159-bed Level 1A tertiary care VA hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 60.3% with EndoTool, from 0.0604% to 0.024% of patients.
  • Incidence of hyperglycemia >=200 mg/dL decreased 17.4%, from 55.7% to 46.0% of blood glucose readings.
  • Percentage of blood glucose readings within the target range of 140-180 mg/dL increased 60.1% with EndoTool; from 16.3% to 26.1%.
  • Percentage of on-time blood glucose checks increased 53.4% with EndoTool, from 52.6% to 80.7%, indicating improved nursing compliance.
Conclusions

Use of an electronic glucose monitoring system (EndoTool) for managing diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) has potential for increasing the safety and effectiveness of glycemic control and minimizing glycemic variability; it is shown to deliver significantly lower incidence of hypoglycemia and hyperglycemia than paper-based protocols as well as a greater percentage of blood glucose readings in range and improved nursing compliance with blood glucose checks.

References

Authors

Madeline Brown, PharmD; Justin Roberts, PharmD, BCPS; Cole Smith, PharmD, BCPS; Dakota Eash, PharmD Candidate.

Source

Published in Journal of Diabetes Science and Technology.

Year

2023 (Print) 2022 (Online)

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.